Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Centogene N.V. (CNTG)

Centogene N.V. (CNTG)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Centogene N.V. AM STRANDE 7 ROSTOCK 2M 18055 DEU

P: 818-011-3500 F: 818-011-3401

Description:

Centogene is a commercial-stage company focused on rare diseases that transforms real-world clinical and genetic data into actionable information for patients, physicians and pharmaceutical companies. The Company's goal is to bring rationality to treatment decisions and to accelerate the development of new orphan drugs by using their knowledge of the global rare disease market, including epidemiological and clinical data and innovative biomarkers.

Key Statistics

Overview:

Market Capitalization, $K 225,621
Shares Outstanding, K 19,861
Annual Sales, $ 146,650 K
Annual Net Income, $ -24,490 K
Last Quarter Sales, $ 78,320 K
Last Quarter Net Income, $ -5,890 K
60-Month Beta -2.15
% of Institutional Shareholders 12.24%
Float, K 19,861
% Float 100.00%

Growth:

1-Year Return -14.09%
3-Year Return 0.00%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Next Earnings Date 09/22/21
Earnings Per Share ttm -0.95
EPS Growth vs. Prev Qtr -228.57%
EPS Growth vs. Prev Year 42.55%
Annual Dividend Rate, $ 0.00
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

CNTG Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -29.84%
Return-on-Assets % -13.19%
Profit Margin % -16.70
Net Margin % N/A
Debt/Equity 0.00
Price/Sales 1.56
Price/Cash Flow N/A
Price/Book 3.00
Book Value/Share 3.83
Interest Coverage -14.06
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar